Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lofexidine in Neonates Experiencing Opioid Withdrawal
NCT06047834Phase 2Active, not recruiting
- Sponsor
- BioCorRx Pharmaceuticals
- Start
- Oct 2023
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lofexidine in neonatal opioid withdrawal syndrome (NOWS), sponsored by BioCorRx Pharmaceuticals. Started Oct 2023; status: active, not recruiting.
02
Drugs
lofexidine
03
Conditions
neonatal opioid withdrawal syndrome (NOWS)
Beyond the preview
Go deeper on NCT06047834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06047834.